Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

ClinicalTrials.gov ID: NCT05389215

Public ClinicalTrials.gov record NCT05389215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 12:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DWN12088 in Patients With Idiopathic Pulmonary Fibrosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blinded, placebo-controlled multicenter study to evaluate the safety and efficacy of DWN12088 in patients with Idiopathic Pulmonary Fibrosis.

Study identification

NCT ID
NCT05389215
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Enrollment
102 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 28, 2022
Primary completion
Oct 12, 2026
Completion
Jan 29, 2027
Last update posted
Jul 15, 2026

2022 – 2027

United States locations

U.S. sites
20
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
Pulmonary Associates, PA Mesa Arizona 85206-1346
Dignity Health Norton Thoracic Institute Phoenix Arizona 85013
The University of California San Francisco San Francisco California 94143
Loyola University Medical Center (LUMC) Maywood Illinois 60153
University of Kansas Medical Center Research Institute, Inc Kansas City Kansas 66160
Tufts Medical Center Boston Massachusetts 02111
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
University of Michigan Health System Michigan Center Michigan 48109
The Lung Research Center, LLC Chesterfield Missouri 63017
Duke University Medical Center Durham North Carolina 27705
Pulmonix Research, LLC Greensboro North Carolina 27403
Legacy Research Institute Portland Oregon 97232
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
The U.S. Department of Veterans Affairs Charleston South Carolina 29401
Lowcountry Lung and Critical Care Charleston South Carolina 29406
Baylor Scott & White Research Institute Dallas Texas 75204
The University of Texas Southwestern Medical Center Dallas Texas 75390-9020
Baylor College of Medicine Houston Texas 77030
The University of Texas Health San Antonio Medical Arts & Research Center San Antonio Texas 78229-3901

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05389215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 15, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05389215 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →